Stem-Cell Breakthrough

The article examines developments in stem cell research. The world's first clinical trial will begin in 2009 on the use of embryonic stem cells to help repair damaged spinal cords. This reflects the expansion of research on the therapeutic use of stem cells from the replacement of damaged cells to the development of drugs and research on the biological origins of diseases.

ACCESSION #

43508566

Related Articles

The article examines developments in stem cell research. The world's first clinical trial will begin in 2009 on the use of embryonic stem cells to help repair damaged spinal cords. This reflects the expansion of research on the therapeutic use of stem cells from the replacement of damaged cells...

An introduction to the journal is presented in which the editor discusses articles on the science and ethic of human induced pluripotent stem (iPS) cells, the human somatic cell reprogramming, and the biological equivalent of the iPS and embryonic stem (ES) cells.

The article discusses the dispute over the issue of using human embryonic stem (ES) in research. The benefit of ES research is said to be infinite for the improvement of clinical treatments of various medical conditions. Critics of ES cell research argue that it is a degradation of human life...

Due to their ability to reproduce the embryological differentiation of nearly all different cellular phenotypes, embryonic stem (ES) cells represent an ideal tool to study processes of embryogenesis under in vitro conditions, in particular the signalling cascades and genes involved in the...

There is increasing support for embryonic stem (ES) cell research on both sides of the Atlantic. In the United States, the outcome is more funding from non-federal sources, despite the current administration's opposing views. In Europe, a similar pragmatic turn is in the making, but the future...

The article reports on progress made in stem cell research and the successful research carried out by a team of Kyoto, Japan scientists at the University of Wisconsin-Madison who took human genes and reprogrammed them into becoming stem cells, eliminating the need for embryonic stem cells....